Skip to main content

Cardinal Health Value Stock - Dividend - Research Selection

Cardinal health

ISIN: US14149Y1082 , WKN: 880206

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield %
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



Description Data
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

Cardinal Health, Inc. operates as an integrated healthcare services and products company worldwide. The company\'s Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare, and consumer products to retailers, hospitals, and other healthcare providers. It offers distribution, inventory management, data reporting, new product launch support, and chargeback administration services to pharmaceutical manufacturers; pharmacy and medication therapy management, and patient outcomes services to hospitals, other healthcare providers, and payers; and consulting, patient support, and other services to pharmaceutical manufacturers and healthcare providers. This segment also operates nuclear pharmacies and manufacturing facilities that manufacture, prepare, and deliver radiopharmaceuticals, as well as operates direct-to-patient specialty pharmacies; offers logistics, marketing, and other services; and repackages generic pharmaceuticals and over-the-counter healthcare products. The company\'s Medical segment manufactures and sources medical, surgical, and laboratory products, including cardiovascular and endovascular products; wound care products; surgical drapes, gowns, and apparel; exam and surgical gloves; fluid suction and collection systems; and incontinence, enteral feeding, urology, operating room supply, electrode and needle, and syringe and sharps disposal product lines. It also distributes medical, surgical, and laboratory products to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers, as well as to patients in the home; and assembles and sells sterile and non-sterile procedure kits. In addition, it offers supply chain services to healthcare providers; and post-acute care management, and transition services and software to hospitals, other healthcare providers, and payers. Cardinal Health, Inc. was founded in 1979 and is headquartered in Dublin, Ohio.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


Buy These 5 Dividend Growth Stocks Amid Conflicting Labor Market Data

2026-01-12
Dividend-growth stocks like CAH stand out as labor data sends mixed signals, offering income stability and growth amid economic uncertainty.

3 Medical Supplies Stocks That Beat the Market Despite Macro Headwinds

2026-01-12
Cardinal Health, McKesson, and Cencora are showing how scale, specialty focus, and execution can drive market-beating returns despite macro pressure.

2 Safe-and-Steady Stocks to Consider Right Now and 1 Facing Headwinds

2026-01-12
Low-volatility stocks may offer stability, but that often comes at the cost of slower growth and the upside potential of more dynamic companies.

How The Story For Cardinal Health (CAH) Is Shifting In Analysts Fair Value Views

2026-01-11
What Is Driving the Updated Fair Value Estimate? The slight move in Cardinal Health's fair value estimate, from US$216.60 to US$222.20 per share, reflects how recent research is weighing progress in the business against ongoing risks. On one side, analysts are reacting to stronger views on earnings power tied to specialty growth, the Solaris acquisition, and steadier core Pharma distribution results. On the other side, they are still flagging questions around recovery in the Global Medical...

Has Cardinal Health (CAH) Run Too Far After A 309% Five Year Share Price Gain?

2026-01-11
If you are wondering whether Cardinal Health's share price still offers value after a strong run, this breakdown will help you frame what the current price could be telling you. The stock recently closed at US$201.11, with returns of 1.5% over the last 30 days, a 2.2% decline year to date, and gains of 67.5% over 1 year, 176.1% over 3 years, and 309.3% over 5 years. Recent coverage around Cardinal Health has largely focused on its role as a major healthcare distributor and its exposure to...

A Look At Cardinal Health (CAH) Valuation As Momentum Meets Modest Discount To Fair Value

2026-01-11
Cardinal Health (CAH) is drawing fresh attention as investors reassess its recent share performance alongside the company’s scale, with revenue of US$234.3b and net income of US$1.6b from its diversified healthcare operations. See our latest analysis for Cardinal Health. The latest share price of US$201.11 sits alongside a 30.33% 3‑month share price return and a 67.50% 1‑year total shareholder return, which points to strong recent momentum after a weaker year‑to‑date share price return. If...

Citigroup Upgrades Cardinal Health (CAH)

2026-01-10

Dividend Champion, Contender, And Challenger Highlights: Week Of Jan 11

2026-01-09

PacBio Stock Dips Post Latest Launch to Expand Multiomics Capabilities

2026-01-09
PACB introduces CiFi, a new sequencing method designed to expand multiomics capabilities without added hardware.

3 MedTech Stocks That Crushed the S&P 500 Over the Past Year

2026-01-09
TransMedics, KORU Medical Systems and Cardinal Health beat the S&P 500 as execution, earnings visibility and company-specific catalysts drove gains.